The best Manufacturer in Nagpur

Eltrombopag 25mg/50mg Tablets – Global Supply with Fast International Delivery Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter from India supplying high-quality Eltrombopag 25mg and 50mg Tablets worldwide with reliable logistics, regulatory support, and fast international shipping across the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. Eltrombopag is a thrombopoietin receptor agonist used to increase platelet production in patients with low platelet counts. It helps reduce bleeding risks and supports management of serious hematological conditions. Product Details Product Name: Eltrombopag Tablets Strengths Available: 25mg / 50mg Dosage Form: Oral Tablets Category: Hematology / Platelet Enhancer Packaging: Custom export packaging available Exporter: Cordium Pharmaceuticals Pvt Ltd, India Uses of Eltrombopag Tablets Eltrombopag Tablets are commonly prescribed for: ✔ Chronic Immune Thrombocytopenia (ITP) with insufficient response to other therapies ✔ Severe Aplastic Anemia management ✔ Thrombocytopenia associated with chronic hepatitis C treatment protocols ✔ Platelet count support in selected hematological disorders under specialist supervision How Eltrombopag Works Eltrombopag stimulates thrombopoietin receptors in bone marrow cells, increasing platelet production and helping maintain safer platelet counts for patients at risk of bleeding complications. Recommended Dosage & Administration Typical starting dosage may range from 25mg to 50mg once daily, depending on condition, age, ethnicity, liver function, and platelet response. Dosage adjustments are based on platelet monitoring and physician assessment. Maximum dose and treatment duration should only be determined by healthcare professionals. Tablets are generally taken on an empty stomach and separated from calcium-rich foods or supplements because absorption may be affected. Important: Do not self-medicate. Eltrombopag requires regular blood monitoring and specialist supervision. Common Side Effects Patients may experience: Headache Nausea Fatigue Fever Diarrhea Cough Elevated liver enzymes Muscle or joint pain Serious risks may include liver toxicity and thrombotic complications, requiring regular monitoring. Seek medical advice if unusual bleeding, jaundice, or severe symptoms occur. Safety & Precautions Liver function monitoring is recommended during therapy Regular platelet count testing is essential Use cautiously in patients with liver disorders Avoid dose modifications without physician guidance Not intended for treatment of all causes of low platelet counts Why Choose Cordium Pharmaceuticals Pvt Ltd? ✓ Trusted pharmaceutical exporter from India ✓ Competitive pricing for bulk orders ✓ International export documentation support ✓ Reliable global logistics network ✓ Fast delivery to United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil ✓ Dedicated customer support for importers, distributors, and healthcare suppliers

Fulvenat Injection (Fulvestrant) is an anti-cancer injectable medicine used in hormone receptor-positive breast cancer treatment. Cordium Pharmaceuticals Pvt Ltd is a trusted global supplier and exporter of Fulvenat Injection from India, serving hospitals, pharmacies, pharma distributors, and personal import requirements across the United States, United Kingdom, France, Germany, Switzerland, Belgium, Singapore, UAE, Saudi Arabia, Nigeria, Kenya, South Africa, Vietnam, Philippines, Indonesia, Brazil, and Mexico. What is Fulvenat Injection (Fulvestrant)? Fulvenat Injection contains Fulvestrant, an estrogen receptor antagonist used primarily for treating hormone receptor-positive advanced or metastatic breast cancer, especially in postmenopausal women. It works by blocking and degrading estrogen receptors that may help certain breast cancer cells grow. Uses of Fulvenat Injection (Fulvestrant) Fulvenat Injection may be prescribed for: Hormone receptor (HR)-positive advanced breast cancer Metastatic breast cancer treatment Breast cancer progression after endocrine therapy Combination therapy with targeted treatments in specific patients Postmenopausal women with HR-positive, HER2-negative breast cancer Important: Use only under supervision of a qualified healthcare professional. Recommended Dosage and Administration Typical recommended dosage: Standard dose: 500 mg administered intramuscularly Usually given on: Day 1 Day 15 Day 29 Then once monthly thereafter Administration is typically performed by healthcare professionals as deep intramuscular injections. Dose adjustments may be needed for certain liver conditions. Note: Dosage schedules may vary according to physician recommendations and patient condition. Precautions Before Using Fulvenat Injection Patients should inform healthcare providers if they have: Liver impairment or liver disease Bleeding disorders Low platelet counts Pregnancy or plans for pregnancy History of allergic reactions Use of blood thinners or anticoagulants Special precautions include: Use cautiously in patients with moderate hepatic impairment Avoid during pregnancy due to fetal risk Breastfeeding is generally not recommended during treatment Careful injection administration is important to reduce injection-site complications Possible Side Effects of Fulvenat Injection Some commonly reported side effects include: Injection site pain Nausea Fatigue Joint pain Headache Hot flashes Back pain Vomiting Loss of appetite Muscle pain Elevated liver enzymes Constipation or cough Seek medical attention if severe allergic reactions or unusual symptoms occur. Storage Information Store refrigerated between 2°C to 8°C Do not freeze Keep protected from excessive heat and sunlight Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd is committed to supplying high-quality pharmaceutical products worldwide. We Supply To: ✔ Hospitals ✔ Pharmacies ✔ Pharma Distributors ✔ Personal Import Requirements ✔ Healthcare Procurement Companies Export Markets: United States | United Kingdom | France | Germany | Switzerland | Belgium | Singapore | UAE | Saudi Arabia | Nigeria | Kenya | South Africa | Vietnam | Philippines | Indonesia | Brazil | Mexico Our Advantages: Reliable export documentation support International shipping assistance Bulk supply capability Quality-focused sourcing Timely global delivery support

What is Etoposide 50mg Capsule? Etoposide 50mg Capsules is an anti-cancer medicine used in chemotherapy treatment. It belongs to a class of medicines called topoisomerase inhibitors, which work by slowing or stopping the growth of cancer cells. Etoposide is commonly prescribed as part of combination chemotherapy protocols for specific cancers. Uses of Etoposide 50mg Capsules Etoposide 50mg Capsules are primarily used in the treatment of: Small cell lung cancer (SCLC) Testicular cancer Certain lymphomas and leukemias (as prescribed by oncologists) Other cancers where oral chemotherapy regimens are recommended Treatment indications may vary depending on physician recommendations and country-specific guidelines. Dosage and Administration Dosage is determined by the treating oncologist based on body surface area, cancer type, treatment protocol, and patient condition. Capsules should be taken exactly as prescribed. Do not change the dose or stop treatment without medical advice. If vomiting occurs after taking a dose, consult your healthcare provider before retaking it. Oral chemotherapy schedules vary and may involve multiple-day treatment cycles. Important: Etoposide is a prescription chemotherapy medicine and should only be used under specialist supervision. Precautions Before Using Etoposide 50mg Patients should inform their healthcare provider about: Existing liver or kidney disease Low blood counts or active infections Previous allergic reactions to chemotherapy medicines Pregnancy or breastfeeding status Current medications due to possible drug interactions History of bone marrow suppression Additional precautions: Regular blood monitoring may be required during treatment. Avoid exposure to infections because chemotherapy can reduce immunity. Handle capsules carefully and follow healthcare instructions for storage and disposal. Common Side Effects of Etoposide 50mg Capsules Some commonly reported side effects include: Nausea and vomiting Hair loss Fatigue or weakness Loss of appetite Mouth sores Low white blood cell counts Increased risk of infections Low platelet counts causing easy bruising or bleeding Serious side effects requiring urgent medical attention may include: Fever or signs of infection Unusual bleeding Severe allergic reactions Breathing difficulty Severe skin reactions Side effects vary among individuals and treatment regimens. Storage Information Store according to product labeling instructions. Keep away from moisture, heat, and direct sunlight. Keep out of reach of children. Follow local regulations for disposal of unused chemotherapy medicines.